Dear Colleagues,
As the editors-in-chief of JCM, we are pleased to announce the winners of the JCM 2019 Best Paper Awards.
The awards have been granted to:
Two Reviews:
Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues
Eija Könönen, Mervi Gursoy and Ulvi Kahraman Gursoy
J. Clin. Med. 2019, 8(8), 1135; https://doi.org/10.3390/jcm8081135
The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity
Yueyuan Zhou, Yusuke Yamamoto, Zhongdang Xiao and Takahiro Ochiya
J. Clin. Med. 2019, 8(7), 1025; https://doi.org/10.3390/jcm8071025
One research article:
Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR
Tara K. Sigdel, Felipe Acosta Archila, Tudor Constantin, Sarah A. Prins, Juliane Liberto, Izabella Damm, Parhom Towfighi, Samantha Navarro, Eser Kirkizlar, Zachary P. Demko, Allison Ryan, Styrmir Sigurjonsson, Reuben D. Sarwal, Szu- Chuan Hseish, Chitranon Chan-On, Bernhard Zimmermann, Paul R. Billings, Solomon Moshkevich and Minnie M. Sarwal
J. Clin. Med. 2019, 8(1), 19; https://doi.org/10.3390/8010019
Each winner (corresponding author) will receive 1000 CHF and a chance to publish a paper in JCM in 2022.
We would like to congratulate the winners on their accomplishments. We would like to take this opportunity to thank all the nominated research groups of the above exceptional papers for their contributions to JCM, and thank the Award Committee for voting and helping with these awards.
Editors-in-Chief
Prof. Dr. Emmanuel Andrès, Prof. Dr. Michael G. Hennerici, JCM
Eligibility and Requirements
Irritable Bowel Syndrome (IBS) is a functional disorder of the gastrointestinal tract characterized by abdominal pain and altered bowel habits. It has a prevalence of 10 to 25% in the United States and has a high disease burden, as evidenced by reduc...
Artificial intelligence (AI), notably Generative Adversarial Networks, has the potential to transform medical and patient education. Leveraging GANs in medical fields, especially cosmetic surgery, provides a plethora of benefits, including upholding...
Obepi-Roche 2020 by the “Ligue Contre l’Obésité” (League Against Obesity) estimated overweight and obesity prevalence in France. The adopted methodology was chosen to be as similar as possible to that of a series of qu...
(1) Background: Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related mortality worldwide. Up to 50% of patients with CRC develop metastatic CRC (mCRC). Surgical and systemic therapy advances can now o...
Due to the key role of tumor necrosis factor-alpha (TNF-α) in the pathogenesis of immunoinflammatory diseases, TNF-α inhibitors have been successfully developed and used in the clinical treatment of autoimmune disorders. Currently, five a...
